Loch

Loch is a biotechnology company developing a high-throughput, single-molecule protein sequencing platform designed to transform the field of proteomics. The company's technology aims to provide a comprehensive view of the proteome by identifying and quantifying proteins and their post-translational modifications with extreme sensitivity and scale. By moving beyond the constraints of traditional mass spectrometry, Loch's platform enables researchers to uncover novel biomarkers and gain deeper insights into complex disease biology. The company is positioned as a foundational tools provider for the next generation of drug discovery and precision diagnostics. Loch's platform has the potential to accelerate the identification of therapeutic targets and the development of personalized medicine.